CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)

Study of Cilofexor in Adults With Primary Sclerosing Cholangitis

NCT03890120 ·Status: TERMINATED ·Phase: PHASE3

CM-101 in PSC Patients -The SPRING Study

NCT04595825 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC)

NCT04133792 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis

NCT05397379 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Safety and Efficacy of HK-660S in Patients With Primary Sclerosing Cholangitis

NCT05866809 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH

NCT05591079 ·Status: COMPLETED ·Phase: PHASE2

Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD）

NCT05795517 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis

NCT04060147 ·Status: TERMINATED ·Phase: PHASE1

To Study the Safety and Efficacy of Simvastatin in Patients With Hepatopulmonary Syndrome in Cirrhosis.

NCT05187715 ·Status: UNKNOWN ·Phase: NA

A Phase II Clinical Trial of Chiglitazar for NASH

NCT05193916 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis

NCT05642468 ·Status: TERMINATED ·Phase: PHASE2

A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.

NCT05627362 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects

NCT06037577 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis

NCT02943460 ·Status: COMPLETED ·Phase: PHASE2

Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study

NCT05912387 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP1601, and the Effect of Food on ZSP1601 Pharmacokinetics

NCT03392779 ·Status: COMPLETED ·Phase: PHASE1

Safety and Effectiveness of Sulfasalazine in the Treatment of Liver Fibrosis/Cirrhosis.

NCT06293378 ·Status: RECRUITING ·Phase: NA

A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease

NCT02927314 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASH

NCT05118360 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH

NCT02784444 ·Status: COMPLETED ·Phase: PHASE2

A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

NCT02413372 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) .

NCT06168383 ·Status: COMPLETED ·Phase: PHASE2

Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)

NCT02128958 ·Status: COMPLETED ·Phase: PHASE2

Phase 1 Pharmacokinetic Study Of CP-945598 In Patients With NASH

NCT00706537 ·Status: COMPLETED ·Phase: PHASE1

Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)

NCT07104201 ·Status: RECRUITING ·Phase: EARLY_PHASE1